Skip to main content
Fig. 1 | Gut Pathogens

Fig. 1

From: Production of highly immunogenic and safe Triton X-100 produced bacterial ghost vaccine against Shigella flexneri 2b serotype

Fig. 1

DNA and protein released in the culture supernatants of treated and untreated S. flexneri cells. A bar chart presenting the amount of released proteins and DNA from Sf-BGC/TW80 and Sf-BGC/TX100 compared to native, untreated cells (S. flexneri 2b serotype ATCC 12022) The X-axis represents the type of supernatant used in this experiment. The Y-axis represents the recorded absorbance of each preparation using Nanodrop at 280 nm and 260 nm to determine the amount of released proteins and DNA, respectively. (***) indicate a significant difference between the released amounts of protein and DNA, respectively, compared to native, untreated S. flexneri 2b serotype ATCC 12022. Data represent mean standard errors of the mean (SEM) obtained using one-way ANOVA data analysis. The difference is considered significant if P < 0.0001

Back to article page

Gut Pathogens

ISSN: 1757-4749